Identification of early molecular markers for breast cancer. - Wikidata - awgldk - TriplyDB

Identification of early molecular markers for breast cancer.

Identification of early molecular markers for breast cancer.

http://www.wikidata.org/entity/Q34608080

about

Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy.A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women Claudin 1 expression in basal-like breast cancer is related to patient age Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication?FNTM: a server for predicting functional networks of tissues in mouse.Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer?DEPDC1 is a novel cell cycle related gene that regulates mitotic progression PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair.Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.Autophagy induction causes a synthetic lethal sensitization to ribonucleotide reductase inhibition in breast cancer cells.Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS).Alterations in osteopontin modify muscle size in females in both humans and mice.Cyclins and cell cycle control in cancer and disease.BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.Ductal carcinoma in situ of the breast: morphological and molecular features implicated in progression.Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer The dual role of asporin in breast cancer progression.Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors.Genome-wide screen identifies a novel prognostic signature for breast cancer survival.FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer.Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes.Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.3'UTR shortening and EGF signaling: implications for breast cancer.Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.

P2860

Q24336569-620FFD47-9365-459F-9256-922FAA190397 Q27316936-309AB36D-3EDB-4AA6-BAC2-F7DF48906535 Q28259224-F1103288-2C04-4CAE-ABBA-FB89B90D5132 Q28487347-580167C8-7E1F-452E-BC7D-BB19F1E0CFFB Q28534478-090DE624-C65A-4BE9-A25B-BBCD21091E84 Q30423830-0327A8BA-42D1-43EA-B633-90A8A3469382 Q33835581-EA503019-4187-4E43-A695-319BC3BCF62C Q34374191-8E792AFB-A8D0-47DA-AB9C-E4403E445A5A Q34584632-4B48C673-4658-43F5-B00F-21F0667AE1F1 Q34737360-CBB1DDB3-479A-40DA-8FFF-97D194B7215D Q34747887-52BC9B22-0C74-44A8-9630-514E6DCD57EC Q35021021-9ECFFAC5-C959-4417-81CE-49481AFC93B5 Q35153105-DEC5B5F9-C898-470C-98FE-AB6337195443 Q35810193-6C4A98F5-8306-4CFF-BB10-5AD9824DF03F Q35979090-0FDFCE7C-C748-4CEE-AFAE-178E6436CCF8 Q36079472-23D56C9C-9F9B-408C-BA2A-1F11B2C1E2F5 Q36126937-0C29755D-968B-4ABD-8F6F-DBACFF3DEA53 Q36214336-278BDF79-A3CB-4FA4-9FCF-8E67F1DD57F2 Q36233838-48FF3A48-4618-42B9-8924-FA8652935AB1 Q36495922-C90D9E13-B3A1-4176-83A4-344EBF8226CC Q36625687-3F0E1B43-1427-4075-82DF-AFD1C5EA1240 Q36722574-9141E865-E86B-484A-911C-5DA0FAB43A88 Q36739017-1C975C85-1B5B-4AE5-A361-B12D24435F17 Q36750301-4E0E8988-3C74-44BD-8A23-04A7D5688BC6 Q36781227-82B4E1C0-E213-45EB-BE91-A25F838A3E0A Q36796438-B5E920D4-F3E3-411D-813D-A1275BBF5511 Q37172715-32FC5026-B49C-4A5F-B97B-962DCAFF9013 Q37390796-69F1950E-063E-444D-9A44-14425BD0FED9 Q37490083-7B058326-BC0E-42F5-8D18-6F700ADAA62C Q37507568-210E5CB6-51F8-44CF-AAD3-0F53036E4123 Q37588410-730CFD49-1D32-4CD1-8593-C7BF97487D0F Q37630882-0F2EB6D5-A52E-4F1B-BCAA-E6C988036426 Q37706736-8B1F800A-D8AD-481E-988F-BE73FE1B9E50 Q37716906-51F3BF05-CCCB-470E-90A3-624B40FA537E Q37723914-9C958930-B8AD-4BD6-A420-0A374F5D198F Q38496038-6BBE5848-C453-41BB-8E0D-A9C0005030FA Q38637559-754877D9-A610-4A28-B157-06D6700F1330 Q38753216-FE7B9216-2454-4DC6-8D08-E1B28B60A625 Q38833441-66D1CD83-D516-4FB5-9365-38747D53CEC4 Q38904950-7AE2F402-4AF9-447E-8967-41DB9F9DC96A

P2860

Identification of early molecular markers for breast cancer.

http://www.wikidata.org/entity/Q34608080

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Identification of early molecular markers for breast cancer.

@ast

Identification of early molecular markers for breast cancer.

@en

Identification of early molecular markers for breast cancer.

@nl

type

label

Identification of early molecular markers for breast cancer.

@ast

Identification of early molecular markers for breast cancer.

@en

Identification of early molecular markers for breast cancer.

@nl

prefLabel

Identification of early molecular markers for breast cancer.

@ast

Identification of early molecular markers for breast cancer.

@en

Identification of early molecular markers for breast cancer.

@nl

P1433

Q34608080-59122D14-A2DF-4268-9FAC-29276FEC586F

P1476

Q34608080-13B43BA2-6BE4-4EB1-8085-5661F6ABEED1

P2093

Q34608080-16B3E4C7-6549-4BE1-8F6E-3D54584E3365

Q34608080-1C087808-7D51-47BD-9895-7B644B5CF9DB

Q34608080-50C999F0-64C7-42D0-AEE3-C0250B851D19

Q34608080-9F79CC83-6318-42D9-AA09-0BEB792E0157

Q34608080-ABDA5279-3485-4F9F-B5FF-F7161FC549CB

Q34608080-AE411AC4-7740-4C54-9E5A-791B18DB07FF

P2860

Q34608080-0155A7E4-3FA1-4EE7-BBCB-E5F005896379

Q34608080-09107CFE-1464-4954-801F-65B56673BCBB

Q34608080-093E4E23-C28E-4A0F-B3CD-08F4626A28C9

Q34608080-0F023AE1-E5C0-4B65-8C66-81E0272720CE

Q34608080-17427788-4292-412A-AAC5-06320D10F6C6

Q34608080-198F20E5-F0D7-47FB-A212-A576B9EFA15C

Q34608080-1C538D62-FC33-46A4-A3A9-11EE073527FD

Q34608080-1C60D319-C9AD-4C18-912C-6926A745DCAC

Q34608080-1C6317BE-185D-44FC-8169-6F9C196D3678

Q34608080-333FA763-4A8B-40E5-A0FC-10903A8A28B9

P2888

Q34608080-4B89B07B-0A25-4219-8037-D81167A3768B

P304

Q34608080-9FF6D09C-8244-495D-8822-49D79E3E8BF1

P31

Q34608080-BA83A677-A1C3-43A8-A7E8-019EF19A63D2

P356

Q34608080-C68BE783-04DF-48DA-929E-8770094469FA

P433

Q34608080-BE089868-0754-4CD4-8355-200A2E843B65

P478

Q34608080-907CCB02-A482-466F-BB35-281690B6F419

P577

Q34608080-D50DD1CC-7F15-44A0-9D1E-3B7C5B8AFB43

P5875

Q34608080-52CA41B4-2F9A-45AB-89BF-32C323198CF4

P6179

Q34608080-3E86A476-17E9-4AD0-99E3-39859C5375B0

P698

Q34608080-168D396F-F131-4E86-83C9-CE8C5CA4BBBD

P932

Q34608080-5812C374-C5D5-47D7-8371-4C7C614A3735

P356

1476-4598-10-15

P1433

Molecular Cancer

P1476

Identification of early molecular markers for breast cancer.

@en

P2093

Anja Sterner-Kock

http://www.w3.org/2001/XMLSchema#string

Céline Kretschmer

http://www.w3.org/2001/XMLSchema#string

Friederike Siedentopf

http://www.w3.org/2001/XMLSchema#string

Peter M Schlag

http://www.w3.org/2001/XMLSchema#string

Winfried Schoenegg

http://www.w3.org/2001/XMLSchema#string

Wolfgang Kemmner

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis

NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

FOXM1, a typical proliferation-associated transcription factor

X chromosomal abnormalities in basal-like human breast cancer

The role of osteopontin in tumor progression and metastasis in breast cancer

Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.

Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set.

P2888

1476-4598-10-15

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-10-15

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49830093

http://www.w3.org/2001/XMLSchema#string

P6179

1007815174

http://www.w3.org/2001/XMLSchema#string

P698

21314937

http://www.w3.org/2001/XMLSchema#string

P932

3045364

http://www.w3.org/2001/XMLSchema#string